News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
567,043 Results
Type
Article (45722)
Company Profile (121)
Press Release (521200)
Multimedia
Podcasts (84)
Webinars (12)
Section
Business (155464)
Career Advice (2412)
Deals (29039)
Drug Delivery (120)
Drug Development (71305)
Employer Resources (151)
FDA (15856)
Job Trends (12485)
News (279020)
Policy (30559)
Tag
Academia (2369)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (84)
Alliances (37023)
ALS (93)
Alzheimer's disease (1458)
Antibody-drug conjugate (ADC) (145)
Approvals (15801)
Artificial intelligence (254)
Autoimmune disease (27)
Automation (12)
Bankruptcy (318)
Best Places to Work (9663)
BIOSECURE Act (22)
Biosimilars (115)
Biotechnology (73)
Bladder cancer (80)
Brain cancer (27)
Breast cancer (279)
Cancer (2225)
Cardiovascular disease (195)
Career advice (2016)
Career pathing (33)
CAR-T (145)
Cell therapy (426)
Cervical cancer (21)
Clinical research (58062)
Collaboration (746)
Company closure (2)
Compensation (559)
Complete response letters (29)
COVID-19 (2645)
CRISPR (45)
C-suite (234)
Cystic fibrosis (99)
Data (2166)
Decentralized trials (2)
Denatured (15)
Depression (54)
Diabetes (277)
Diagnostics (5494)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (42)
Drug discovery (104)
Drug pricing (126)
Drug shortages (30)
Duchenne muscular dystrophy (100)
Earnings (66768)
Editorial (47)
Employer branding (20)
Employer resources (136)
Events (92022)
Executive appointments (674)
FDA (17198)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (669)
Gene editing (110)
Generative AI (22)
Gene therapy (326)
GLP-1 (809)
Government (4158)
Grass and pollen (6)
Guidances (146)
Healthcare (15614)
Huntington's disease (25)
IgA nephropathy (29)
Immunology and inflammation (147)
Indications (26)
Infectious disease (2794)
Inflammatory bowel disease (140)
Inflation Reduction Act (9)
Influenza (51)
Intellectual property (90)
Interviews (451)
IPO (14577)
IRA (48)
Job creations (3204)
Job search strategy (1672)
Kidney cancer (11)
Labor market (37)
Layoffs (523)
Leadership (23)
Legal (7186)
Liver cancer (74)
Lung cancer (314)
Lymphoma (151)
Machine learning (9)
Management (51)
Manufacturing (314)
MASH (77)
Medical device (11607)
Medtech (11610)
Mergers & acquisitions (14998)
Metabolic disorders (755)
Multiple sclerosis (81)
NASH (22)
Neurodegenerative disease (104)
Neuropsychiatric disorders (33)
Neuroscience (2015)
NextGen: Class of 2025 (5206)
Non-profit (3376)
Now hiring (19)
Obesity (415)
Opinion (224)
Ovarian cancer (74)
Pain (95)
Pancreatic cancer (82)
Parkinson's disease (152)
Partnered (16)
Patents (237)
Patient recruitment (104)
Peanut (45)
People (44292)
Pharmaceutical (35)
Pharmacy benefit managers (22)
Phase I (17233)
Phase II (25249)
Phase III (20544)
Pipeline (1334)
Policy (176)
Postmarket research (2377)
Preclinical (7151)
Press Release (37)
Prostate cancer (111)
Psychedelics (36)
Radiopharmaceuticals (222)
Rare diseases (406)
Real estate (4409)
Recruiting (60)
Regulatory (21450)
Reports (33)
Research institute (2101)
Resumes & cover letters (402)
Rett syndrome (4)
RNA editing (3)
RSV (47)
Schizophrenia (78)
Series A (123)
Series B (82)
Service/supplier (10)
Sickle cell disease (55)
Special edition (18)
Spinal muscular atrophy (132)
Sponsored (33)
Startups (2826)
State (1)
Stomach cancer (16)
Supply chain (72)
Tariffs (54)
The Weekly (68)
Vaccines (781)
Venture capitalists (44)
Weight loss (297)
Women's health (32)
Worklife (20)
Date
Last 7 days (897)
Last 30 days (2875)
Last 365 days (30189)
2025 (11195)
2024 (32371)
2023 (36365)
2022 (46519)
2021 (50207)
2020 (47192)
2019 (38128)
2018 (28868)
2017 (28818)
2016 (27344)
2015 (30614)
2014 (24113)
2013 (19574)
2012 (21042)
2011 (21514)
2010 (19457)
Location
Africa (683)
Alabama (48)
Alaska (6)
Arizona (180)
Arkansas (10)
Asia (32442)
Australia (5674)
California (5951)
Canada (1656)
China (443)
Colorado (248)
Connecticut (275)
Delaware (142)
Europe (78766)
Florida (886)
Georgia (194)
Hawaii (1)
Idaho (39)
Illinois (471)
India (24)
Indiana (268)
Iowa (11)
Japan (156)
Kansas (86)
Kentucky (14)
Louisiana (7)
Maine (62)
Maryland (878)
Massachusetts (4454)
Michigan (191)
Minnesota (354)
Mississippi (1)
Missouri (73)
Montana (12)
Nebraska (19)
Nevada (60)
New Hampshire (53)
New Jersey (1674)
New Mexico (15)
New York (1646)
North Carolina (939)
North Dakota (6)
Northern California (2655)
Ohio (168)
Oklahoma (8)
Oregon (28)
Pennsylvania (1285)
Puerto Rico (10)
Rhode Island (21)
South America (1050)
South Carolina (23)
South Dakota (1)
Southern California (2249)
Tennessee (91)
Texas (833)
United States (21986)
Utah (168)
Virginia (141)
Washington D.C. (63)
Washington State (523)
West Virginia (3)
Wisconsin (57)
567,043 Results for "fidia farmaceutici s p a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Nemysis Limited Announces a Strategic Alliance With Bruno Farmaceutici S.p.A.
Nemysis is pleased to announce that it has entered into a Strategic Alliance Agreement with Bruno Farmaceutici S.p.A. for the mutual advancement of the portfolio and sales of each company.
November 8, 2023
·
2 min read
Deals
Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc
Chiesi Farmaceutici S.p.A. announced the completion of the acquisition of Amryt Pharma Plc, a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing, and commercializing novel treatments for rare diseases.
April 12, 2023
·
3 min read
Deals
Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc
Chiesi Farmaceutici S.p.A. and Amryt Pharma Plc announced that the companies have entered into a definitive agreement under which Chiesi will acquire Amryt.
January 8, 2023
·
12 min read
Press Releases
Inspire Medical Systems, Inc. Announces the Addition of Paul T. Hoff, M.D., M.S. and Ruchir P. Patel, M.D., F.A.C.P. as Vice President, Senior Medical Directors
April 21, 2025
·
4 min read
Deals
Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici
Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici.
March 22, 2023
·
6 min read
Business
Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications
Gossamer Bio, Inc. and Chiesi Farmaceutici S.p.A announced that they have entered into a global collaboration and license agreement to develop and commercialize seralutinib.
May 6, 2024
·
9 min read
Press Releases
David P. King Joins Truvian’s Advisory Board
January 13, 2025
·
2 min read
Press Releases
Acadia Pharmaceuticals Set to Join S&P SmallCap 600
December 31, 2024
·
1 min read
Press Releases
Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A
January 14, 2025
·
4 min read
Press Releases
Priothera Appoints Dr. Jens Hasskarl as Chief Medical Officer to Drive Late-Stage Clinical Development of Mocravimod, a S1P Receptor Modulator for Acute Myeloid Leukemia (AML)
May 6, 2025
·
3 min read
1 of 56,705
Next
